Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine.

Abdallah, Hoda Y; Ibrahim, Maha E; Abd El-Fadeal, Noha M; Ali, Dina A; Elsehrawy, Gehad G; Badr, Rasha E; Hassoba, Howayda M

Abdallah, Hoda Y; Ibrahim, Maha E; Abd El-Fadeal, Noha M; Ali, Dina A; Elsehrawy, Gehad G; Badr, Rasha E; Hassoba, Howayda M.

Afiliación

Abdallah HY; Medical Genetics Unit, Department of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Ibrahim ME; Center of Excellence in Molecular & Cellular Medicine, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Abd El-Fadeal NM; Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Ali DA; Center of Excellence in Molecular & Cellular Medicine, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Elsehrawy GG; Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Badr RE; Oncology Diagnostic Unit, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Hassoba HM; Center of Excellence in Molecular & Cellular Medicine, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

Diagnostics (Basel) ; 12(7)2022 Jun 27.

Article en En | MEDLINE | ID: mdl-35885466

Palabras clave

ATIC; DHFR; GGH; SLC19A1; allelic discrimination; genotyping; methotrexate; rheumatoid arthritis; single-nucleotide polymorphism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google